LLY stock profile - insider summary
- Name
- Date
- Title
- Total Bought
- Total Sold
- Updated
- IssuerCik
- SubKey
- netTransacted
-
Ricks David A2023/03/31SVP and Pres, Lilly Bio-Meds170728-408462023-03-3100000594780000059478129882
-
Ricks David A2023/03/30SVP and Pres, Lilly Bio-Meds170728-408462023-03-3000000594780000059478129882
-
Hedley Mary Lynne2023/03/29512023-03-290000059478000005947851
-
Zakrowski Donald A2023/03/28Chief Accounting Officer46594-272002023-03-280000059478000005947819394
-
Hedley Mary Lynne2023/03/27512023-03-270000059478000005947851
-
Hedley Mary Lynne2023/03/26512023-03-260000059478000005947851
-
LECHLEITER JOHN C2023/03/25President and COO155390-766662023-03-250000059478000005947878724
-
Skovronsky Daniel2023/03/24SVP, CSO, and Pres. LRL1105572023-03-2400000594780000059478110557
-
Hedley Mary Lynne2023/03/23512023-03-230000059478000005947851
-
Hedley Mary Lynne2023/03/22512023-03-220000059478000005947851
Related News

ASML Stock Falls 14% Since February High—Can NASDAQ:ASML Reclaim Its Uptrend?
TradingNEWS Archive
28.04.25

Tesla (NASDAQ:TSLA) Advances to $295.50 on Full Self-Driving Gains and Production Efficiencies
TradingNEWS Archive
28.04.25

Pfizer Stock at $22.50—Could That 7.6% Yield and a $64 B Revenue Outlook Turn PFE Around?
TradingNEWS Archive
25.04.25